Facebook Twitter LinkedIn Google Plus RSS

Actavis, Valeant announce marketing deal

By ,

Actavis Inc., in Parsippany, announced today it will exclusively market a generic version Zovirax for Valeant Pharmaceuticals International Inc.

In addition, Valeant has granted Actavis the exclusive right to co-promote Zovirax cream to obstetricians and gynecologists in the United States, and Actavis has granted Valeant the exclusive right to co-promote its Cordran product in the United States. Terms were not disclosed.

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close